Terms ending in 2035
Every in-force patent on Amyris, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,041,092 | Methods for Genomic Integration In force · High confidence | Amyris, Inc. | In force | High confidence | |
| US 11,390,888 | Methods for Genomic Integration In force · High confidence | Amyris, Inc. | In force | High confidence | |
| US 9,476,065 | Methods for Genomic Integration In force · High confidence | Amyris, Inc. | In force | High confidence | |
| US 12,473,556 | Methods for Stabilizing Production of Acetyl-Coenzyme a Derived Compounds In force · High confidence | Total Marketing Services | In force | High confidence | |
| US 10,071,034 | Solvent Compositions In force · High confidence | Amyris, Inc. | In force | High confidence | |
| US 10,695,273 | Compositions Containing Bio-Based Farnesene or Compounds Derived Therefrom and Their Use in Consumer and Industrial Products In force · High confidence | Amyris, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Amyris, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.